Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antimicrobial Resistance
100%
Web-based
100%
Hospital Inpatients
100%
Antimicrobial Use
100%
Adult Hospital
100%
Global Point Prevalence Survey
100%
Antimicrobial
66%
Antibiotic Prescribing
50%
Latin America (LATAM)
33%
Antibiotic Guidelines
33%
Healthcare-associated Infections
16%
International Networks
16%
Infectious Disease Hospital
16%
Transplantation
16%
Intensive Care Unit
16%
Bone Marrow
16%
Antibiotics
16%
Fluoroquinolones
16%
Patient Characteristics
16%
Penicillin
16%
Antibacterial Treatment
16%
East Asia
16%
Targeted Treatment
16%
Hospitalized Patients
16%
Multidrug-resistant Organisms
16%
Antibacterial Agents
16%
Neonate
16%
Therapeutic Indications
16%
Antibiotic Resistance
16%
Prescribing Guidelines
16%
Adult children
16%
Carbapenems
16%
Pediatric Hospital
16%
Central Asia
16%
Oncohematology
16%
Third-generation Cephalosporins
16%
Local Antibiotics
16%
Low-income
16%
South Asia
16%
Antibiotic Prescription
16%
Surveillance Methods
16%
Guideline Compliance
16%
Low-middle Income
16%
Detailed Data
16%
Adult Inpatients
16%
β-lactamase Inhibitor
16%
Internet-based Survey
16%
Middle-income Countries
16%
Upper-middle Income Countries
16%
Surgical Ward
16%
Medical Ward
16%
Voluntary Participation
16%
Prescribing Quality
16%
Latin West
16%
Oncology Ward
16%
Targeted Antibacterial
16%
West Asia
16%
Medicine and Dentistry
Prevalence
100%
Antiinfective Agent
100%
Hospital Inpatient
100%
Oncology
10%
Infectious Disease
10%
Pediatrics
10%
Intensive Care Unit
10%
Antibiotics
10%
Antibiotic Therapy
10%
Quinolone Derivative
10%
Bone Marrow Transplantation
10%
Penicillin
10%
Hematology
10%
Patient Characteristics
10%
Neonate
10%
Healthcare Associated Infection
10%
Penicillinase
10%
Third Generation Cephalosporin
10%
Carbapenem Derivative
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Antiinfective Agent
100%
Diseases
9%
Antibiotics
9%
Quinolone Derivative
9%
Penicillinase
9%
Penicillin
9%
Carbapenem Derivative
9%
Third Generation Cephalosporin
9%
Healthcare Associated Infection
9%